04/16/2024
11:16 AM | Johnson & Johnson (Filer)
| Form 8-K/A | |
04/16/2024
6:06 AM | Johnson & Johnson (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
4:05 PM | Contineum Therapeutics, Inc. (Issuer)
Johnson & Johnson (Reporting)
Johnson & Johnson Innovation - JJDC, Inc. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/10/2024
4:12 PM | Contineum Therapeutics, Inc. (Subject)
Johnson & Johnson (Filed by)
| Form SC 13G | |
04/05/2024
4:29 PM | Johnson & Johnson (Filed by)
Shockwave Medical, Inc. (Subject)
| Form DFAN14A | |
03/27/2024
8:48 AM | Johnson & Johnson (Subject)
National Legal & Policy Center (Filed by)
| Form PX14A6G | |
03/13/2024
3:28 PM | Broadhurst Vanessa (Reporting)
Johnson & Johnson (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
03/13/2024
3:36 PM | Broadhurst Vanessa (Reporting)
Johnson & Johnson (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
6:42 AM | Johnson & Johnson (Filer)
| Form ARS | |
03/13/2024
6:35 AM | Johnson & Johnson (Filer)
| Form DEF 14A | |
03/13/2024
6:37 AM | Johnson & Johnson (Filer)
| Form DEFA14A | |
03/13/2024
6:39 AM | Johnson & Johnson (Filer)
| Form DEFA14A | |
03/06/2024
2:42 PM | CVRx, Inc. (Issuer)
Johnson & Johnson (Reporting)
Johnson & Johnson Innovation - JJDC, Inc. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
4:58 PM | Johnson & Johnson (Issuer)
Taubert Jennifer L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
4:54 PM | Decker Robert J (Reporting)
Johnson & Johnson (Issuer)
Johnson & Johnson (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:12 PM | Johnson & Johnson (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/15/2024
4:23 PM | Ambrx Biopharma, Inc. (Subject)
Johnson & Johnson (Filed by)
| Form DFAN14A | |
02/15/2024
3:53 PM | Decker Robert J (Reporting)
Johnson & Johnson (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:53 PM | Broadhurst Vanessa (Reporting)
Johnson & Johnson (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:53 PM | Forminard Elizabeth (Reporting)
Johnson & Johnson (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:53 PM | Duato Joaquin (Reporting)
Johnson & Johnson (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:53 PM | Hait William (Reporting)
Johnson & Johnson (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:53 PM | Fasolo Peter (Reporting)
Johnson & Johnson (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:53 PM | Johnson & Johnson (Issuer)
Schmid Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
5:36 PM | Johnson & Johnson (Issuer)
Wengel Kathryn E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
5:36 PM | Decker Robert J (Reporting)
Johnson & Johnson (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
5:36 PM | Johnson & Johnson (Issuer)
Schmid Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
5:36 PM | Duato Joaquin (Reporting)
Johnson & Johnson (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
5:36 PM | Johnson & Johnson (Issuer)
Swanson James D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
5:36 PM | Fasolo Peter (Reporting)
Johnson & Johnson (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
5:36 PM | Johnson & Johnson (Issuer)
Taubert Jennifer L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
5:36 PM | Forminard Elizabeth (Reporting)
Johnson & Johnson (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
5:36 PM | Johnson & Johnson (Issuer)
Wolk Joseph J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
5:36 PM | Hait William (Reporting)
Johnson & Johnson (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
5:36 PM | Broadhurst Vanessa (Reporting)
Johnson & Johnson (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
6:24 PM | Decker Robert J (Reporting)
Johnson & Johnson (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
6:24 PM | Broadhurst Vanessa (Reporting)
Johnson & Johnson (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
6:24 PM | Hait William (Reporting)
Johnson & Johnson (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
6:24 PM | Fasolo Peter (Reporting)
Johnson & Johnson (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
6:24 PM | Johnson & Johnson (Issuer)
Schmid Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
6:24 PM | Johnson & Johnson (Issuer)
Swanson James D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
This Apple-like Innovator is Revolutionizing Healthcare (Ad) AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing.
Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world. Click here to learn more about the booming eHealth industry |
02/12/2024
6:24 PM | Forminard Elizabeth (Reporting)
Johnson & Johnson (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
6:25 PM | Johnson & Johnson (Issuer)
Wolk Joseph J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
6:25 PM | Johnson & Johnson (Issuer)
Wengel Kathryn E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
6:25 PM | Duato Joaquin (Reporting)
Johnson & Johnson (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
6:25 PM | Johnson & Johnson (Issuer)
Taubert Jennifer L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
11:55 AM | Johnson & Johnson (Subject)
McEvoy Ashley (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024
11:35 AM | Johnson & Johnson (Subject)
Taubert Jennifer L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/06/2024
3:24 PM | Johnson & Johnson (Subject)
McEvoy Ashley (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
4:07 PM | BiomX Inc. (Subject)
Johnson & Johnson (Filed by)
| Form SC 13G/A | |
02/02/2024
3:52 PM | CVRx, Inc. (Subject)
Johnson & Johnson (Filed by)
| Form SC 13G/A | |
02/02/2024
3:32 PM | Johnson & Johnson (Filed by)
Johnson & Johnson (Filed by)
Nanobiotix S.A. (Subject)
| Form SC 13G/A | |
01/30/2024
11:46 AM | Johnson & Johnson (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/29/2024
3:50 PM | Ambrx Biopharma, Inc. (Subject)
Johnson & Johnson (Filed by)
| Form DFAN14A | |
01/24/2024
11:51 AM | Johnson & Johnson (Filed by)
Kenvue Inc. (Subject)
| Form SC 13G | |
01/23/2024
6:45 AM | Johnson & Johnson (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2024
4:08 PM | Ambrx Biopharma, Inc. (Subject)
Johnson & Johnson (Filed by)
| Form DFAN14A | |
01/08/2024
4:22 PM | Ambrx Biopharma, Inc. (Subject)
Johnson & Johnson (Filed by)
| Form DFAN14A | |
01/08/2024
7:22 AM | Johnson & Johnson (Filer)
| Form DEFA14A | |
12/08/2023
3:33 PM | Johnson & Johnson (Issuer)
Woods Eugene A. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/07/2023
4:17 PM | HEWSON MARILLYN A (Reporting)
Johnson & Johnson (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
3:42 PM | Johnson & Johnson (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2023
6:52 AM | Johnson & Johnson (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/30/2023
3:30 PM | Johnson & Johnson (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/27/2023
3:56 PM | Johnson & Johnson (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
3:36 PM | Johnson & Johnson (Issuer)
Schmid Timothy (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/23/2023
3:48 PM | Johnson & Johnson (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2023
6:33 AM | Johnson & Johnson (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2023
3:36 PM | HEWSON MARILLYN A (Reporting)
Johnson & Johnson (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2023
6:46 AM | Johnson & Johnson (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/25/2023
4:02 PM | Johnson & Johnson (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/25/2023
3:53 PM | Johnson & Johnson (Reporting)
Kenvue Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2023
6:04 AM | Johnson & Johnson (Subject)
| Form SC TO-I/A | |
08/23/2023
5:37 AM | Johnson & Johnson (Subject)
| Form 425 | |
08/21/2023
5:52 AM | Johnson & Johnson (Subject)
| Form SC TO-I/A | |
08/21/2023
5:38 AM | Johnson & Johnson (Subject)
| Form 425 | |
08/18/2023
4:11 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/17/2023
3:53 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/17/2023
5:23 AM | Johnson & Johnson (Subject)
| Form SC TO-I/A | |
08/16/2023
8:22 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/16/2023
3:43 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/15/2023
3:43 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/14/2023
3:44 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/11/2023
3:51 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/04/2023
3:32 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/03/2023
3:39 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/03/2023
7:03 AM | Johnson & Johnson (Subject)
| Form SC TO-I/A | |
08/01/2023
3:39 PM | Johnson & Johnson (Subject)
| Form 425 | |
07/31/2023
3:06 PM | Johnson & Johnson (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/28/2023
7:59 PM | Johnson & Johnson (Subject)
| Form 425 | |
07/27/2023
4:52 PM | Hait William (Reporting)
Johnson & Johnson (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
The Next Nvidia? (Ad) The Next Nvidia?
Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about. Go here now for this breaking story. |
07/27/2023
4:52 PM | Fasolo Peter (Reporting)
Johnson & Johnson (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2023
3:51 PM | Johnson & Johnson (Subject)
| Form 425 | |
07/24/2023
3:04 PM | Johnson & Johnson (Subject)
| Form 425 | |
07/24/2023
3:04 PM | Johnson & Johnson (Subject)
| Form 425 | |
07/24/2023
3:04 PM | Johnson & Johnson (Subject)
Kenvue Inc. (Filed by)
| Form 425 | |
07/24/2023
3:04 PM | Johnson & Johnson (Subject)
| Form 425 | |
07/24/2023
3:04 PM | Johnson & Johnson (Subject)
| Form 425 | |
07/24/2023
3:05 PM | Johnson & Johnson (Subject)
| Form 425 | |
07/24/2023
3:05 PM | Johnson & Johnson (Subject)
| Form 425 | |
